Cargando…
Optimizing COVID‐19 Candidate Therapeutics: Thinking Without Borders
Autores principales: | Rayner, Craig R., Smith, Patrick F., Hershberger, Kevin, Wesche, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485940/ https://www.ncbi.nlm.nih.gov/pubmed/32212378 http://dx.doi.org/10.1111/cts.12790 |
Ejemplares similares
-
ICU without borders
por: Ostermann, Marlies, et al.
Publicado: (2023) -
Learning without Borders: Asynchronous and Distance Learning in the Age of COVID-19 and Beyond
por: Brady, Anna K., et al.
Publicado: (2020) -
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19
por: Rayner, Craig R., et al.
Publicado: (2020) -
Following data as it crosses borders during the COVID-19 pandemic
por: Plasek, Joseph M, et al.
Publicado: (2020) -
Statins as candidate therapeutic agents for coronavirus disease 2019 (COVID-19)
por: Li, Sheng-De, et al.
Publicado: (2021)